Rights Issue15 May 2026, 05:21 pm
Solara Active Pharma Sciences: Rights Issue Update
AI Summary
Solara Active Pharma Sciences Ltd. has released a monitoring agency report by CRISIL Ratings Limited for the quarter ended March 31, 2026, regarding the utilization of proceeds from its Rights Issue. The report confirms no deviation in the use of issue proceeds from the stated objectives in the Letter of Offer. The Rights Issue took place between May 28, 2024, and June 11, 2024, with an issue size of ₹449.95 crore.
Key Highlights
- CRISIL Ratings monitored the utilization of Rights Issue proceeds.
- No deviation reported in the utilization of issue proceeds.
- Rights Issue size was ₹449.95 crore.
- Issue period was May 28, 2024 to June 11, 2024.
Price Impact
More from SOLARA